Cargando…

Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Uncertainty underlies the effectiveness of somatostatin analogues for slowing the progression of polycystic kidney or liver disease. METHODS: Eligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as therapy for patients with polycystic kidney diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suwabe, Tatsuya, Barrera, Francisco J., Rodriguez-Gutierrez, Rene, Ubara, Yoshifumi, Hogan, Marie C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462725/ https://www.ncbi.nlm.nih.gov/pubmed/34559824 http://dx.doi.org/10.1371/journal.pone.0257606

Ejemplares similares

Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume Was Reduced by Rigorous Blood Pressure Control
por: Suwabe, Tatsuya, et al.
Publicado: (2021)

Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD: A systematic review and meta-analysis of randomized trials
por: Suwabe, Tatsuya, et al.
Publicado: (2018)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation
por: Suwabe, Tatsuya, et al.
Publicado: (2023)

Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts
por: Hamanoue, Satoshi, et al.
Publicado: (2018)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Paraneoplastic Polymyositis Due to Renal Cell Carcinoma in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Noda-Narita, Shoko, et al.
Publicado: (2021)

Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence
por: Suwabe, Tatsuya, et al.
Publicado: (2021)

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease
por: Sumida, Keiichi, et al.
Publicado: (2013)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017)

Development of an enterocutaneous fistula from an intestinal perforation in a patient with autosomal dominant polycystic kidney disease
por: Nakayama, Yuki, et al.
Publicado: (2022)

Scanning electron microscopy of polycystic liver disease
por: Kojima, Kazutaka, et al.
Publicado: (2018)

Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease
por: Hasegawa, Eiko, et al.
Publicado: (2016)

Effects of somatostatin analogs on uptake of radiolabeled somatostatin analogs on imaging: a systematic review and meta-analysis
por: Wang, Rang, et al.
Publicado: (2023)

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
por: Kunizawa, Kyohei, et al.
Publicado: (2018)

Evidence-based clinical practice guidelines for polycystic kidney disease 2014
por: Horie, Shigeo, et al.
Publicado: (2016)

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018)

Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
por: Griffiths, Joshua, et al.
Publicado: (2020)

Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case–control study
por: Suwabe, Tatsuya, et al.
Publicado: (2016)

Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues
por: Suwabe, Tatsuya
Publicado: (2020)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease
por: Messchendorp, A. Lianne, et al.
Publicado: (2018)

Renal Squamous Cell Carcinoma-related Polymyositis in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Terakawa, Kanako, et al.
Publicado: (2021)

PKD1-associated autosomal dominant polycystic kidney disease with glomerular cysts presenting with nephrotic syndrome caused by focal segmental glomerulosclerosis
por: Oda, Yasuhiro, et al.
Publicado: (2019)

Renal Transcatheter Arterial Embolization for ADPKD
por: Oda, Yasuhiro, et al.
Publicado: (2020)

Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis
por: Pita-Gutierrez, Francisco, et al.
Publicado: (2013)

Antiproliferative effects of somatostatin analogs in endocrine tumours
por: Zatelli, Maria Chiara
Publicado: (2009)

A review of the use of somatostatin analogs in oncology
por: Keskin, Ozge, et al.
Publicado: (2013)

Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
por: Costa, Ricardo, et al.
Publicado: (2013)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

The Coordination Abilities of New Cyclic Analogs of Somatostatin
por: Marciniak, Aleksandra, et al.
Publicado: (2016)

Somatostatin Analogs in Clinical Practice: A Review
por: Gomes-Porras, Mariana, et al.
Publicado: (2020)

Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county
por: Suwabe, Tatsuya, et al.
Publicado: (2020)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
por: Rossi, Valentina, et al.
Publicado: (2019)

Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic Review
por: Morland, David, et al.
Publicado: (2023)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
por: Matsuura, Ryo, et al.
Publicado: (2016)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
por: Eychenne, Romain, et al.
Publicado: (2020)

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study
por: Lantinga, Marten A., et al.
Publicado: (2016)

MON-288 TSH Deficiency in Patients on Somatostatin Analog for TSH-PitNET
por: Illouz, Frederic, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uh5urp1t5cd1vms9ep7shdt2g1